Optimer
Pharmaceuticals^®, Inc.

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. We focus on medicines that make a significant difference in the lives of patients and reduce the burden of disease.

DIFICID^®

DIFICID (fidaxomicin) tablets, an antibacterial drug, is the first drug indicated in adults (> 18 years of age) for Clostridium difficile-associated diarrhea to be approved by FDA in over 25 years.

LEARN MORE
Careers

Optimer^® is building its team of professionals who share our vision to develop and commercialize innovative hospital specialty products that have a positive impact on society

LEARN MORE
Investigator-Initiated Studies

Learn about our Investigator Initiated Study program

LEARN MORE
DIFICID Rx Assist™ Program

The DIFICID Rx Assist Program supports patient access to DIFICID^® (fidaxomicin) tablets

LEARN MORE

Optimer Pharmaceuticals | Innovative Hospital Specialty Products

DIFICID Rx Assist™ Program

Submitted by site_admin on Wed, 2012-11-14 19:01

Read more about DIFICID Rx Assist™ Program
Log in to post comments

Jersey City, NJ

Submitted by site_admin on Thu, 2012-08-09 15:16

Read more about Jersey City, NJ
Log in to post comments

Toronto, ON

Submitted by site_admin on Thu, 2012-08-09 15:15

Read more about Toronto, ON
Log in to post comments

San Diego, CA

Submitted by site_admin on Thu, 2012-08-09 15:13

Read more about San Diego, CA

Important Safety Information

Submitted by site_admin on Tue, 2012-08-07 14:45

Read more about Important Safety Information

Prescribing Information

Submitted by site_admin on Tue, 2012-08-07 14:43

Read more about Prescribing Information

Investigator-Initiated Studies

Submitted by site_admin on Wed, 2012-07-25 18:05

Read more about Investigator-Initiated Studies
Log in to post comments

Careers

Submitted by site_admin on Wed, 2012-07-25 18:03

Read more about Careers
Log in to post comments

DIFICID<sup>®</sup>

Submitted by site_admin on Wed, 2012-07-25 17:36

Read more about DIFICID®
Log in to post comments

Investors

Submitted by site_admin on Tue, 2012-07-24 17:19

Read more about Investors

Recent News

Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer

Optimer Reports First Quarter 2013 Financial Results

Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results

DIFICID® (fidaxomicin) Tablets Approved in Australia

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Investors

Optimer is committed to serving the best interests of our shareholders

We are committed to serving the best interests of our shareholders. Please click here for more information.

DIFICID Rx Assist™

The DIFICID Rx Assist™ Program supports patient access to DIFICID® (fidaxomicin) tablets

The DIFICID Rx Assist Program supports patient access to DIFICID^® (fidaxomicin) tablets.

Page last updated on April 2013, 21525

Copyright © 2013 Optimer Pharmaceuticals^®, Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The product discussed herein may have different product labeling in different countries.